Claims
- 1. A compound of formula
- 2. The compound according to claim 1 wherein at least one A is a halogen.
- 3. The compound according to claim 1 wherein said compound is of Formula I or II and M is manganese.
- 4. The compound according to claim 1 wherein said compound is of Formula I or III.
- 5. The compound according to claim 4 wherein said compound is of Formula I and M is manganese.
- 6. A method of protecting cells from oxidant-induced toxicity comprising contacting said cells with a protective amount of the compound of claim 1 under conditions such that the protection is effected.
- 7. The method according to claim 6 wherein said cells are mammalian cells.
- 8. A method of treating a pathological condition of a patient resulting from oxidant-induced toxicity comprising administering to said patient an effective amount of the compound of claim 1 under conditions such that the treatment is effected.
- 9. A method of treating a pathological condition of a patient resulting from degradation of NO′, comprising administering to said patient an effective amount of the compound of claim 1 under conditions such that the treatment is effected.
- 10. A method of treating a patient for inflammatory lung disease comprising administering to said patient an effective amount of the compound of claim 1 under conditions such that the treatment is effected.
Parent Case Info
[0001] This application claims priority from Provisional Application No. 60/386,454, filed Jun. 7, 2002, the content of which is incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60386454 |
Jun 2002 |
US |